report cover

Liver Fibrosis Treatment Market, Global Outlook and Forecast 2023-2029

  • 12 April 2023
  • Life Sciences
  • 67 Pages
  • Report code : 24WT-7637797

Liver Fibrosis Treatment and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Liver Fibrosis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liver Fibrosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liver Fibrosis Treatment Overall Market Size
2.1 Global Liver Fibrosis Treatment Market Size: 2022 VS 2029
2.2 Global Liver Fibrosis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liver Fibrosis Treatment Players in Global Market
3.2 Top Global Liver Fibrosis Treatment Companies Ranked by Revenue
3.3 Global Liver Fibrosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Liver Fibrosis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Liver Fibrosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liver Fibrosis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Liver Fibrosis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Liver Fibrosis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Liver Fibrosis Treatment Market Size Markets, 2022 & 2029
4.1.2 PPARa Agonist
4.1.3 ACE Inhibitors
4.1.4 Hepatotropic Drug
4.1.5 Others
4.2 By Type - Global Liver Fibrosis Treatment Revenue & Forecasts
4.2.1 By Type - Global Liver Fibrosis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Liver Fibrosis Treatment Revenue, 2024-2029
4.2.3 By Type - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liver Fibrosis Treatment Market Size, 2022 & 2029
5.1.2 Alcoholic Liver Disease
5.1.3 Chronic Viral Hepatitis
5.1.4 Non-alcoholic Fatty Liver Disease
5.1.5 Others
5.2 By Application - Global Liver Fibrosis Treatment Revenue & Forecasts
5.2.1 By Application - Global Liver Fibrosis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Liver Fibrosis Treatment Revenue, 2024-2029
5.2.3 By Application - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Liver Fibrosis Treatment Market Size, 2022 & 2029
6.2 By Region - Global Liver Fibrosis Treatment Revenue & Forecasts
6.2.1 By Region - Global Liver Fibrosis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Liver Fibrosis Treatment Revenue, 2024-2029
6.2.3 By Region - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Liver Fibrosis Treatment Revenue, 2018-2029
6.3.2 US Liver Fibrosis Treatment Market Size, 2018-2029
6.3.3 Canada Liver Fibrosis Treatment Market Size, 2018-2029
6.3.4 Mexico Liver Fibrosis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Liver Fibrosis Treatment Revenue, 2018-2029
6.4.2 Germany Liver Fibrosis Treatment Market Size, 2018-2029
6.4.3 France Liver Fibrosis Treatment Market Size, 2018-2029
6.4.4 U.K. Liver Fibrosis Treatment Market Size, 2018-2029
6.4.5 Italy Liver Fibrosis Treatment Market Size, 2018-2029
6.4.6 Russia Liver Fibrosis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Liver Fibrosis Treatment Market Size, 2018-2029
6.4.8 Benelux Liver Fibrosis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Liver Fibrosis Treatment Revenue, 2018-2029
6.5.2 China Liver Fibrosis Treatment Market Size, 2018-2029
6.5.3 Japan Liver Fibrosis Treatment Market Size, 2018-2029
6.5.4 South Korea Liver Fibrosis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Liver Fibrosis Treatment Market Size, 2018-2029
6.5.6 India Liver Fibrosis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Liver Fibrosis Treatment Revenue, 2018-2029
6.6.2 Brazil Liver Fibrosis Treatment Market Size, 2018-2029
6.6.3 Argentina Liver Fibrosis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liver Fibrosis Treatment Revenue, 2018-2029
6.7.2 Turkey Liver Fibrosis Treatment Market Size, 2018-2029
6.7.3 Israel Liver Fibrosis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Liver Fibrosis Treatment Market Size, 2018-2029
6.7.5 UAE Liver Fibrosis Treatment Market Size, 2018-2029
7 Liver Fibrosis Treatment Companies Profiles
7.1 Gilead Sciences, Inc.
7.1.1 Gilead Sciences, Inc. Company Summary
7.1.2 Gilead Sciences, Inc. Business Overview
7.1.3 Gilead Sciences, Inc. Liver Fibrosis Treatment Major Product Offerings
7.1.4 Gilead Sciences, Inc. Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.1.5 Gilead Sciences, Inc. Key News & Latest Developments
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Summary
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Liver Fibrosis Treatment Major Product Offerings
7.2.4 Merck & Co., Inc. Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.2.5 Merck & Co., Inc. Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Liver Fibrosis Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Company Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Liver Fibrosis Treatment Major Product Offerings
7.4.4 Johnson and Johnson Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.4.5 Johnson and Johnson Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Liver Fibrosis Treatment Major Product Offerings
7.5.4 Novartis AG Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Vertex Pharmaceuticals Incorporated
7.6.1 Vertex Pharmaceuticals Incorporated Company Summary
7.6.2 Vertex Pharmaceuticals Incorporated Business Overview
7.6.3 Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Major Product Offerings
7.6.4 Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.6.5 Vertex Pharmaceuticals Incorporated Key News & Latest Developments
7.7 Pfizer Inc.
7.7.1 Pfizer Inc. Company Summary
7.7.2 Pfizer Inc. Business Overview
7.7.3 Pfizer Inc. Liver Fibrosis Treatment Major Product Offerings
7.7.4 Pfizer Inc. Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.7.5 Pfizer Inc. Key News & Latest Developments
7.8 FibroGen, Inc.
7.8.1 FibroGen, Inc. Company Summary
7.8.2 FibroGen, Inc. Business Overview
7.8.3 FibroGen, Inc. Liver Fibrosis Treatment Major Product Offerings
7.8.4 FibroGen, Inc. Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.8.5 FibroGen, Inc. Key News & Latest Developments
7.9 Pharmaxis Limited
7.9.1 Pharmaxis Limited Company Summary
7.9.2 Pharmaxis Limited Business Overview
7.9.3 Pharmaxis Limited Liver Fibrosis Treatment Major Product Offerings
7.9.4 Pharmaxis Limited Liver Fibrosis Treatment Revenue in Global Market (2018-2023)
7.9.5 Pharmaxis Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Liver Fibrosis Treatment Market Opportunities & Trends in Global Market
Table 2. Liver Fibrosis Treatment Market Drivers in Global Market
Table 3. Liver Fibrosis Treatment Market Restraints in Global Market
Table 4. Key Players of Liver Fibrosis Treatment in Global Market
Table 5. Top Liver Fibrosis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Liver Fibrosis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Liver Fibrosis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Liver Fibrosis Treatment Product Type
Table 9. List of Global Tier 1 Liver Fibrosis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Fibrosis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Liver Fibrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Liver Fibrosis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Liver Fibrosis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Liver Fibrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Liver Fibrosis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Liver Fibrosis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Liver Fibrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Liver Fibrosis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Liver Fibrosis Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Liver Fibrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Liver Fibrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Liver Fibrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Liver Fibrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Liver Fibrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Gilead Sciences, Inc. Company Summary
Table 31. Gilead Sciences, Inc. Liver Fibrosis Treatment Product Offerings
Table 32. Gilead Sciences, Inc. Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Sciences, Inc. Key News & Latest Developments
Table 34. Merck & Co., Inc. Company Summary
Table 35. Merck & Co., Inc. Liver Fibrosis Treatment Product Offerings
Table 36. Merck & Co., Inc. Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Merck & Co., Inc. Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Liver Fibrosis Treatment Product Offerings
Table 40. Bristol-Myers Squibb Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Johnson and Johnson Company Summary
Table 43. Johnson and Johnson Liver Fibrosis Treatment Product Offerings
Table 44. Johnson and Johnson Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson and Johnson Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Liver Fibrosis Treatment Product Offerings
Table 48. Novartis AG Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Vertex Pharmaceuticals Incorporated Company Summary
Table 51. Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Product Offerings
Table 52. Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Vertex Pharmaceuticals Incorporated Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Liver Fibrosis Treatment Product Offerings
Table 56. Pfizer Inc. Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. FibroGen, Inc. Company Summary
Table 59. FibroGen, Inc. Liver Fibrosis Treatment Product Offerings
Table 60. FibroGen, Inc. Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. FibroGen, Inc. Key News & Latest Developments
Table 62. Pharmaxis Limited Company Summary
Table 63. Pharmaxis Limited Liver Fibrosis Treatment Product Offerings
Table 64. Pharmaxis Limited Liver Fibrosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Pharmaxis Limited Key News & Latest Developments
List of Figures
Figure 1. Liver Fibrosis Treatment Segment by Type in 2022
Figure 2. Liver Fibrosis Treatment Segment by Application in 2022
Figure 3. Global Liver Fibrosis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Liver Fibrosis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Liver Fibrosis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liver Fibrosis Treatment Revenue in 2022
Figure 8. By Type - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Liver Fibrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Liver Fibrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 16. US Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 28. China Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Liver Fibrosis Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Liver Fibrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Gilead Sciences, Inc. Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co., Inc. Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson and Johnson Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Vertex Pharmaceuticals Incorporated Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer Inc. Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. FibroGen, Inc. Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pharmaxis Limited Liver Fibrosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Liver Fibrosis Treatment and Forecast Market

Leave This Empty: